MMS22L and neoplasm: Previous studies have shown that MMS22L plays critical roles in the DNA damage response and repair, affecting the response of tumour cells to DNA-damaging agents, such as camptothecin (CPT), ionising radiation (IR), hydroxyurea (HU), and methyl methanesulfonate (MMS) (29–32).